Literature DB >> 27358282

Presence of the hyperintense acute reperfusion marker on MRI after mechanical thrombectomy for large vessel occlusion is associated with worse early neurological recovery.

Rishi Gupta1, Chung-Huan Johnny Sun2, Dustin Rochestie1, Kumiko Owada1, Ahmad Khaldi1, Andrew K Johnson1, Christopher M Horn1.   

Abstract

BACKGROUND: Mechanical thrombectomy has become the accepted treatment for large vessel occlusion in acute ischemic stroke. Unfortunately, a large cohort of patients do not achieve functional independence with treatment, even though the results are more robust than with medical management. The hyperintense acute reperfusion marker (HARM) on MRI is an indication of the breakdown of the blood-brain barrier and reperfusion injury.
OBJECTIVE: To examine the hypothesis that the presence of HARM on MRI correlates with worse neurological recovery after reperfusion therapy.
METHODS: We retrospectively reviewed 35 consecutive patients who between February 24, 2016 and April 23, 2016 underwent MRI to determine the presence of HARM after thrombectomy for anterior circulation large vessel occlusion. Demographic, radiographic imaging, and outcome data were collected. Univariate and binary logistic regression models were performed to assess predictors for improvement of the National Institutes of Health Stroke Scale (NIHSS) score by ≥8 points at 24 hours.
RESULTS: The 35 patients studied had an average age of 64±14 years of age with a median NIHSS score of 15 (IQR 9-20). Eighteen patients (51%) were found to have a HARM-positive MRI. In univariate analysis, patients with HARM were older, had lower reperfusion rates and more postprocedural hemorrhages. In binary logistic regression modeling, the absence of HARM was independently associated with a ≥8-point NIHSS score improvement at 24 hours (OR=7.14, 95% CI 1.22 to 41.67).
CONCLUSIONS: This preliminary analysis shows that the presence of HARM may be linked to worse neurological recovery 24 hours after thrombectomy. Reperfusion injury may affect the number of patients achieving functional independence after treatment. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Stroke; Thrombectomy

Mesh:

Year:  2016        PMID: 27358282     DOI: 10.1136/neurintsurg-2016-012498

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  5 in total

1.  Frequency of Blood-Brain Barrier Disruption Post-Endovascular Therapy and Multiple Thrombectomy Passes in Acute Ischemic Stroke Patients.

Authors:  Marie Luby; Amie W Hsia; Zurab Nadareishvili; Kaylie Cullison; Noorie Pednekar; Malik Muhammad Adil; Lawrence L Latour
Journal:  Stroke       Date:  2019-06-26       Impact factor: 7.914

2.  Intra-Arterial Injection of Thrombin as Rescue Therapy of Vessel Perforation during Mechanical Thrombectomy for Acute Ischemic Stroke.

Authors:  Tingyu Yi; Wenhuo Chen; Yanmin Wu; Zhinan Pan; Xiaohui Lin; Dinglai Lin; Rongcheng Chen; Xiufeng Zheng
Journal:  Brain Sci       Date:  2022-06-10

3.  Usefulness of hyperintense acute reperfusion marker sign in patients with transient neurologic symptom.

Authors:  Jihoon Kang; Hyuksool Kwon; Cheol Kyu Jung; Hee-Joon Bae; Moon-Ku Han; Beom Joon Kim; You Hwan Jo
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

4.  Ipsilateral blooming of microbleeds after Hyperintense Acute Reperfusion Marker sign in an ischemic Stroke patient, a case report.

Authors:  Luigi Francesco Saccaro; Imen Bekri; Maxime De Malherbe; Intissar Hmida; Fernando Pico
Journal:  BMC Neurol       Date:  2022-04-14       Impact factor: 2.474

Review 5.  CSF enhancement on post-contrast fluid-attenuated inversion recovery images; a systematic review.

Authors:  Whitney M Freeze; Merel van der Thiel; Jeroen de Bresser; Catharina J M Klijn; Ellis S van Etten; Jacobus F A Jansen; Louise van der Weerd; Heidi I L Jacobs; Walter H Backes; Susanne J van Veluw
Journal:  Neuroimage Clin       Date:  2020-10-02       Impact factor: 4.881

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.